Advertisement

WHO to temporarily stop study of malaria drug

A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. Photo: AP/ Rafiq Maqbool. A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020.

The Associated Press
Updated: May 25, 2020 12:05 PM
Created: May 25, 2020 11:59 AM

The World Health Organization said that it will temporarily drop hydroxychloroquine — the malaria drug U.S. President Trump said he is taking — from its global study into experimental COVID-19 treatments, saying that its experts need to review all available evidence to date.

In a news briefing on Monday, WHO director-general Tedros Adhanom Ghebreyesus said that in light of a paper published last week in the Lancet, that showed people taking hydroxychloroquine were at higher risk of death and heart problems than those who were not, there would be “a temporary pause” on the hydroxychloroquine arm of its global clinical trial.

Advertisement
Comment on Facebook
Advertisement

Twins open season July 24 at White Sox, feature 7 home games vs. Indians

New rules: Foreign pupils must leave US if classes go online

DPS, Valerie Castile announce traffic stop guideline updates to state's driver's manual

'Pop-up' legal clinic helps businesses damaged after riots, looting

Small business aid went beyond hard-hit companies, data show

Advertisement